Skip to main content
SpringerLink
Log in

Invited review: Invasive Bladder cancer—Possible future treatment considerations

  • Bladder Cancer
  • Published:
Urological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adolphs H-D, Bastian HP (1983) Chemoimmune prophylaxis of superficial bladder cancer. J Urol 129:29–32

    Google Scholar 

  2. Ahmed T, Yagoda A, Needles B, Scher HI, Watson RC, Geller N (1985) Vinblastine and methotrexate for advanced bladder cancer. J Urol 133:602–604

    Google Scholar 

  3. Bloom HJG, Hendry WF, Wallace DM, Skeet RG (1982) Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 54:136–151

    Google Scholar 

  4. Blumberg N, Agarwal MM, Chuang C (1985) Relation between recurrence of cancer of the colon and blood transfusion. Br Med J 290:1037–1039

    Google Scholar 

  5. Blumenreich MS, Yagoda A, Natale RB, Watson RC (1982) Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors. Cancer 50:435–438

    Google Scholar 

  6. Burrows L, Tartter P (1982) Effect of blood transfusions on colonic malignancy recurrence rate. Lancet II:662

    Google Scholar 

  7. Brosnan SA (1982) Experience with bacillus Calmette-Guerin in patients with superficial carcinoma. J Urol 128:27–30

    Google Scholar 

  8. Carmichael J, Cornbleet MA, MacDougall RH, Allan SG, Ducan W, Chisholm GD, Smyth JF (1985) Cis-platin and methotrexate in the treatment of transitional cell carcinoma of the urinary tract. Br J Urol 57:299–302

    Google Scholar 

  9. Chopin DK, DeKernion JB, Rosenthal DL, Fahey JL (1985) Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J Urol 134(2):260–265

    Google Scholar 

  10. Corcoran MO, Thomas DM, Lim A, Berry RJ, Milroy EJG (1985) Invasive bladder cancer treated by radical external radiotherapy. Br J Urol 57:40–42

    Google Scholar 

  11. Cordon-Cardo C, Bander NH, Fradet Y, Finstad CL, Whitmore WF, Lloyd KO, Oettgen HF, Melamed MR, Old LJ (1984) Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. J Histochem Cytochem 32:1035–1040

    Google Scholar 

  12. Creaven PJ (1984) Platinum analogs as potential new drugs for bladder cancer. Urology XXIII:54–60

    Google Scholar 

  13. Dillman RO, Royston I (1984) Applications of monoclonal antibodies in cancer therapy. Br Med Bull 40:240–246

    Google Scholar 

  14. Droller MJ (1984) Immunotherapy in genitourinary neoplasia. In Zincke H (ed) Urologic clinic of North America: urothelial cancer. Saunders, Philadelphia, pp 643–657

    Google Scholar 

  15. Editorial (1984) Drugs that can cause cancer. Lancet I:261–262

  16. Fossa SD, Gudmundsen TE (1981) Single durg chemotherapy with 5FU and adriamycin in metastatic bladder carcinoma. Br J Urol 53:320–323

    Google Scholar 

  17. Fradet Y, Cordon-Cardo C, Thomson T, Daly ME, Whitmore WF Jr, Lloyd KO, Melamed MR, Old LJ (1984) Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci 81:224–228

    Google Scholar 

  18. Garcia-Giralt E, Auvert J, Lachand AT, Botto H, Abbou C, Hannoun M, Pouillart P, Palangie T, Jouve M, Morin Ph (1981) Combined chemotherapy in the management of metastatic bladder cancer. Br J Urol 53:318–319

    Google Scholar 

  19. Hall RR, Newling DWW, Ramsden PD, Richards B, Robinson MRG, Smith PH (1984) Treatment of invasive bladder cancer by local resection and high dose methotrexate. Br J Urol 56: 668–672

    Google Scholar 

  20. Herr HW, Pinsky CM, Whitmore WF Jr, Oettgen HF, Melamed MR (1983) Effect of intravesical bacillus Calmette Guerin (BCG) on carcinoma in situ of the bladder. Cancer 51:1323–1326

    Google Scholar 

  21. Herr HW, Pinsky CM, Whitmore WF, Sogani PG, Oettgen HF, Melamed MR (1985) Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors. Urology XXV:119–123

    Google Scholar 

  22. Hill DE, Ford KS, Soloway MS (1985) Radical cystectomy and adjuvant chemotherapy. Urology XXV:151–154

    Google Scholar 

  23. Hope-Stone HF, Oliver RTD, England HR, Blandy JP (1984) T3 bladder cancer: salvage rather than elective cystectomy after radiotherapy. Urology XXIV:315–320

    Google Scholar 

  24. Huland H, Otto U, Droese M, Kloppel G (1984) Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival. J Urol 132:27–29

    Google Scholar 

  25. Jaske G, Frommhold H, Nedden DZ (1985) Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder. Cancer 55:1659–1664

    Google Scholar 

  26. Jones HC, Swinney J (1961) Thio-TEPA in the treatment of tumours of the bladder. Lancet II:615–618

    Google Scholar 

  27. Kaye SB, MacFarlane JR, McHattie I, Hart AJL (1985) Chemotherapy before radiotherapy for T3 bladder cancer. Br J Urol 57:434–437

    Google Scholar 

  28. Koontz WW Jnr, Prout GR Jr, Smith W, Frable WJ, Minnis JE (1981) The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder. J Urol 125:307–312

    Google Scholar 

  29. Lamm DL (1985) Bacillus Calmette Guerin immunotherapy for bladder cancer. J Urol 134:40–47

    Google Scholar 

  30. Lamm DL (1985) Personal communication

  31. Lamm DL, Thor DE, Stogdill VD, Radwin HM (1982) Bladder cancer immunotherapy. J Urol 128:931–935

    Google Scholar 

  32. Lamm DL, Thor DE, Winters WD, Stogdill VD, Radwin HM (1981) BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses. Cancer 48: 82–88

    Google Scholar 

  33. McGeorge A, Hart AJL, Rundle JSH, McVie JG, Calman KC (1982) The treatment of advanced carcinoma of the bladder with combination chemotherapy. Br J Urol 54:366–368

    Google Scholar 

  34. Montie JE, Straffon RA, Stewart BH (1984) Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 131:477–482

    Google Scholar 

  35. Morales A (1980) Treatment of carcinoma in situ of the bladder with BCG. A phase II trial. Cancer Immunol Immunother 9: 69–71

    Google Scholar 

  36. Morales A (1984) Immunobiology and immunotherapy of bladder cancer. In: Javadpour N (ed) Bladder cancer, Williams and Wilkins, Baltimore, pp 123–135

    Google Scholar 

  37. Morales A (1984) Long-term results and complications of intracavity bacillus Calmette-Guerin therapy for bladder cancer. J Urol 132:457–459

    Google Scholar 

  38. Morales A, Ottenhof P, Emerson L (1981) Treatment of residual non-inflitrating bladder cancer with bacillus Calmette-Guerin. J Urol 125:649–651

    Google Scholar 

  39. Netto NR Jr, Lemos GC (1983) A comparison of treatment methods for the prophyllaxis of recurrent superficial bladder tumors. J Urol 129:33–34

    Google Scholar 

  40. Netto NR Jr, Lemos GC (1984) Bacillus Calmette Guerin immunotherapy of infiltrating bladder cancer. J Urol 132: 675–677

    Google Scholar 

  41. Oliver RTD, England HR, Risdon RA, Blandy JP (1984) Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma. J Urol 131:483–485

    Google Scholar 

  42. Pang ASD, Morales A (1982) Immunoprophyllaxis of a murine bladder cancer with high dose BCG immunizations. J Urol 127: 1006–1009

    Google Scholar 

  43. Pang ASD, Morales A (1984) Prophyllaxis and therapy of an experimental bladder cancer with biological response modifiers. Abstract 38 AUA 79th Annual Meeting. J Urol 131

  44. Pavone-Macaluso M (1982) Monograph: diagnosis and treatment of superficial bladder tumors. Farmitalia Carlo Erba, p 11

  45. Pavone-Macaluso M, Ingargiola GB, Tripi M, Lamartina M (1984) Intravesical instillation of adriamycin in treatment of bladder cancer. Supplement to Urology XXIII:40–47

    Google Scholar 

  46. Raghavan D (1985) Current status and controversies in the management of genito-urinary cancer. Aust NZ J Surg 55: 243–248

    Google Scholar 

  47. Raghavan D, Pearson B, Duval P, Rogers J, Meagher M, Wines R, Mameghan H, Boulas J, Green D (1985) Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer? J Urol 133:399–402

    Google Scholar 

  48. Ratcliff TL, Shapiro A, Keeley DR, Catalona WJ (1984) Effect of intravesical bacille Calmette-Guerin (BCG) on immune parameters. Abstract 783, AUA 79th Annual Meeting. J Urol 131

  49. Richards B, Bastable JRG, Freedman L, Glashan RW, Harris G, Newling DWW, Robinson MRG, Smith PH, and the Yorkshire Urology Cancer Research Group (1983) Adjuvant chemotherapy with doxorubicin (adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy. Br J Urol 55:386–391

    Google Scholar 

  50. Rosenberg B (1985) Charles F. Kettering Prize. Fundamental studies with cisplatinum. Cancer 55:2303–2316

    Google Scholar 

  51. Scanlon PW, Scott M, Segura JW (1983) A comparison of short-course, low-dose and long-course, high-dose preoperative radiation for carcinoma of the bladder. Cancer 52:1153–1159

    Google Scholar 

  52. Scott RS, Johnson RJR (1984) Radical radiotherapy in treatment of transitional cell carcinoma of urinary bladder. Supplement to Urology XIII:48–50

    Google Scholar 

  53. Shipley WU, Coombs LJ, Einstein AB Jr, Soloway MS, Wajsman Z, Prout GR Jr, and National Bladder Cancer Collaborative Group (1984) Cisplastin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J Urol 132:899–903

    Google Scholar 

  54. Shipley WV, Rose MA, Perrone TL, Mannix CM, Heney NM, Prout GR Jr (1985) Full dose irradiation for patients with invasive bladder carcinoma: Clinical and histological factors prognostic of improved survival. J Urol 134:679–683

    Google Scholar 

  55. Skinner DG, Daniels DR, Lieskovsky G (1984) Current status of adjuvant chemotherapy after radical cystectomy for deeply invasive bladder cancer. Urology XXIV:46–52

    Google Scholar 

  56. Skinner DG, Lieskovsky G (1984) Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol 131:1069–1072

    Google Scholar 

  57. Soloway MS (1978) Cis-diamminedichloroplatinum II in advanced urothelial cancer. J Urol 120:716–719

    Google Scholar 

  58. Soloway MS (1985) Editorial: learning to integrate systemic chemotherapy into a treatment plan for patients with advanced bladder cancer. J Urol 133:440–441

    Google Scholar 

  59. Soloway MS, Ikard M, Scheinberg M, Evans J (1982) Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: a preliminary report. J Urol 128:1031–1033

    Google Scholar 

  60. Steg A, Sicard D, Leleu C, Debre B, Boccon-Gibod L (1985) Systemic complications of intravesical BCG therapy for bladder cancer. Lancet II:899

    Google Scholar 

  61. Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC, Morse MJ, Whitmore WF (1985) Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133:403–407

    Google Scholar 

  62. Tannock IF, Gospodarowicz M, Evans WK (1983) Chemotherapy for metastatic transitional carcinoma of the urinary tract. A prospective trial of methotrexate, adriamycin and cyclophosphamide (MAC) with cis-platinum for failure. Cancer 51:216–219

    Google Scholar 

  63. Tartter PI, Burrows L, Papatestas AE, Lesnick G, Aufses AH Jr (1985) Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 97:225–229

    Google Scholar 

  64. Vessella RL, Chiou RK, Lange PH (1985) Monoclonal antibodies in urology: review of reactivities and applications in diagnosis, staging and therapy. Semin Urol III;158–167

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Royal Brisbane Hospital, Herston, Qld, Australia

    R. A. Gardiner

Authors
  1. R. A. Gardiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gardiner, R.A. Invited review: Invasive Bladder cancer—Possible future treatment considerations. Urol. Res. 14, 191–194 (1986). https://doi.org/10.1007/BF00441112

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00441112

Keywords

Search

Navigation